X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30) 30
humans (28) 28
hematology (24) 24
oncology (23) 23
leukemia, myelogenous, chronic, bcr-abl positive - genetics (19) 19
chronic myeloid leukemia (18) 18
fusion proteins, bcr-abl - genetics (16) 16
imatinib (15) 15
male (15) 15
female (14) 14
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (14) 14
adult (13) 13
chronic myeloid-leukemia (13) 13
cml (13) 13
middle aged (13) 13
imatinib mesylate (12) 12
aged (11) 11
chemistry (11) 11
hemic and lymphatic diseases (11) 11
resistance (10) 10
therapy (10) 10
antineoplastic agents - therapeutic use (9) 9
leukemia (9) 9
recommendations (9) 9
care and treatment (8) 8
metallurgy (8) 8
paper (8) 8
piperazines - therapeutic use (8) 8
pyrimidines - therapeutic use (8) 8
textiles (8) 8
treatment outcome (8) 8
chronic myelogenous leukemia (7) 7
clinical medicine (7) 7
genetic aspects (7) 7
patients (7) 7
polymerase-chain-reaction (7) 7
research (7) 7
tyrosine (7) 7
tyrosine kinase inhibitors (7) 7
bcr-abl (6) 6
cancer research (6) 6
kinases (6) 6
mutation (6) 6
protein kinase inhibitors - therapeutic use (6) 6
young adult (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
analysis (5) 5
benzamides - therapeutic use (5) 5
braiding (5) 5
expression (5) 5
gene expression (5) 5
high-throughput nucleotide sequencing - methods (5) 5
indexing scheme associated with sublasses of section d, relating to textiles (5) 5
indexing scheme associated with sublasses of sectiond, relating totextiles (5) 5
knitting (5) 5
lace-making (5) 5
medical and health sciences (5) 5
medicin och hälsovetenskap (5) 5
molecular response (5) 5
non-woven fabrics (5) 5
polymerase chain reaction (5) 5
protein-tyrosine kinase (5) 5
trimmings (5) 5
usage (5) 5
antineoplastic agents (4) 4
apparatus therefor (4) 4
bcr-abl1 (4) 4
beer (4) 4
benzamides (4) 4
biochemistry (4) 4
biochemistry & molecular biology (4) 4
cancer (4) 4
cladding or plating by soldering or welding (4) 4
cutting by applying heat locally, e.g. flame cutting (4) 4
dasatinib (4) 4
electroforming (4) 4
electrolytic or electrophoretic processes (4) 4
enzymology (4) 4
hematology, oncology and palliative medicine (4) 4
klinisk medicin (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - pathology (4) 4
machine tools (4) 4
management (4) 4
medical prognosis (4) 4
medicine & public health (4) 4
metal-working not otherwise provided for (4) 4
microbiology (4) 4
minimal residual disease (4) 4
mutation or genetic engineering (4) 4
myeloid leukemia (4) 4
performing operations (4) 4
processes for the electrolytic or electrophoretic productionof coatings (4) 4
prognosis (4) 4
rna, messenger - genetics (4) 4
soldering or unsoldering (4) 4
spirits (4) 4
survival (4) 4
transcripts (4) 4
transporting (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 747 - 757
Tyrosine kinase inhibitors (TKIs) have improved the survival of patients with chronic myeloid leukaemia. Many patients have deep molecular responses, a... 
d_article_not_yet_freely_accessible | SURVIVAL | MAJOR MOLECULAR RESPONSE | TREATMENT-FREE REMISSION | ONCOLOGY | IMATINIB DISCONTINUATION | DISEASE | FOLLOW-UP | DASATINIB | WITHDRAWAL SYNDROME | NILOTINIB | PHASE-2 TRIAL | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Clinical Decision-Making | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Polymerase Chain Reaction | Adult | Female | Biomarkers, Tumor - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Drug Administration Schedule | Risk Assessment | Europe | Risk Factors | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Progression-Free Survival | Fusion Proteins, bcr-abl - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Antimitotic agents | Tyrosine | Antineoplastic agents | Analysis | Life Sciences | Hematology | Human health and pathology | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0155959
Bone marrow transplantation or ponatinib treatment are currently recommended strategies for management of patients with chronic myeloid leukemia (CML)... 
CHRONIC MYELOGENOUS LEUKEMIA | CELLS | DOMAIN | MULTIDISCIPLINARY SCIENCES | DASATINIB THERAPY | IMATINIB | RESISTANCE | COMPOUND MUTATIONS | MECHANISMS | CHROMOSOME-POSITIVE LEUKEMIA | CHRONIC MYELOID-LEUKEMIA | Interferon-alpha - pharmacology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Treatment Outcome | Fusion Proteins, bcr-abl - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Interferon-alpha - administration & dosage | Young Adult | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Aged, 80 and over | Adult | Female | Aged | Protein Kinase Inhibitors - pharmacology | High-Throughput Nucleotide Sequencing - methods | Precision Medicine | Blood transfusions | Therapy | Transcription | Leukemia | Bone marrow transplantation | Oncology | Transplantation | BCR gene | Kinases | Ethics | α-Interferon | Immunology | Restoration | Cell cycle | Bone marrow | Pretreatment | Protein-tyrosine kinase | Tyrosine | Immune response | Risk groups | Hematology | Myeloid leukemia | Cloning | Chronic myeloid leukemia | Dentistry | Gene expression | Patients | Medicine | Stem cells | Interferon | Clinical medicine | Mutation
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5211 - 5211
Background BCR/ABL1-like (alias Ph-like) acute lymphoblastic leukemia (ALL) is a clinically challenging subgroup. Its incidence varies from 10% in children to... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1647 - 1647
Introduction: The single nucleotide polymorphism (SNP) rs460089 (G/C) located in the promotor of SLC22A4 (transporter hOCTN1) was identified as a prognostic... 
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2016, Volume 17, Issue 5, pp. 642 - 642
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 11/2018, Volume 103, Issue 12, pp. 2016 - 2025
The fusion oncoprotein BCR-ABL1 exhibits aberrant tyrosine kinase activity and it has been proposed that it deregulates signaling networks involving both... 
STEM-CELLS | INHIBITION | MANAGEMENT | C-MYB | HEMATOLOGY | PU.1 | EXPRESSION | MICRORNA-155 | HEMATOPOIETIC PROGENITORS | IMATINIB MESYLATE
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 5/2015, Volume 141, Issue 5, pp. 887 - 899
Journal Article
Journal Article
CANCERS, ISSN 2072-6694, 06/2019, Volume 11, Issue 6, p. 864
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 9, pp. 1634 - 1648
Journal Article